Ildong Holdings Co., Ltd. 000230

Market Closed
18 Jul, 06:30
7,850. 00
88.19B Market Cap
- P/E Ratio
100% Div Yield
10,201 Volume
0 Eps
Previous Close
Day Range
7,840 8,010
Year Range
7,220 16,790

000230 Chart

Ildong Holdings Co., Ltd. Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Dae-Chang Park CEO
KRX SM Exchange
KR7000230003 ISIN
KR Country
78 Employees
- Last Dividend
5 Mar 2020 Last Split
- IPO Date


Ildong Holdings Co., Ltd., based in Seoul, South Korea, has been a prominent player in the pharmaceutical industry since its inception in 1941. Originally established as Ildong Pharmaceutical Co., Ltd., the company underwent a significant rebranding to Ildong Holdings Co., Ltd. in August 2016, marking a strategic shift in its business operations. With a global footprint, Ildong Holdings is dedicated to developing, manufacturing, and supplying an extensive range of pharmaceutical products, both in South Korea and internationally. The company's relentless commitment to innovation is evident in its development of novel drugs aimed at combating resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and aging. Additionally, Ildong Holdings has diversified its portfolio to include health foods and ingredients, medical devices, and an array of healthcare products, further establishing its role as a comprehensive healthcare provider.

Products and Services

  • New Drug Development: Ildong Holdings is at the forefront of pharmaceutical innovation with its focus on researching and developing new drugs to address critical health issues such as resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and aging.
  • Vitamins and Probiotics: The company manufactures and supplies raw vitamins and probiotics, emphasizing the importance of nutritional supplements in healthcare. Noteworthy products include Biovita, a revered lactobacillus product, and Aronamin, a comprehensive multivitamin supplement.
  • Health Foods and Ingredients: With a commitment to improving wellness, Ildong Holdings engages in the research and production of health foods and ingredients. This segment underscores the company's dedication to offering nutritional solutions that support overall health and well-being.
  • Hyaluronic Acid Production: Recognized for its versatile applications, the company's hyaluronic acid is utilized in various sectors, including pharmaceuticals, medical devices, and cosmetics, showcasing Ildong Holdings' capability in providing high-quality ingredients across industries.
  • Medical Devices and Healthcare Products: The distribution of medical devices, quasi drugs, health supplements, food products, beverages, cosmetics, and sanitary ware forms an integral part of Ildong Holdings' diverse portfolio. The company leverages online platforms to reach a wider customer base, ensuring accessibility to its comprehensive range of healthcare solutions.
  • Pharmaceutical Technology Solutions: Offering pharmaceutical SI consulting, system development, and deployment, including RFID and barcode systems, Ildong Holdings extends its expertise to technological solutions, facilitating advancements in pharmaceutical operations and healthcare delivery.
  • Advertising and Marketing Services: The company also engages in advertising business, tapping into its expansive network and industry knowledge to provide targeted marketing and promotional services, enhancing brand visibility and product outreach.

Contact Information

Address: 2, Baumoe-ro 27-gil, Seoul, South Korea, 06752
Phone: 82 2 526 3114